Tadalafil Sandoz 20 mg film-coated tablets Malta - İngilizce - Medicines Authority

tadalafil sandoz 20 mg film-coated tablets

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - tadalafil - film-coated tablet - tadalafil 20 mg - urologicals

Celecoxib Sandoz 100 mg capsules, hard Malta - İngilizce - Medicines Authority

celecoxib sandoz 100 mg capsules, hard

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - celecoxib - hard capsule - celecoxib 100 mg - antiinflammatory and antirheumatic products

Celecoxib Sandoz 200 mg capsules, hard Malta - İngilizce - Medicines Authority

celecoxib sandoz 200 mg capsules, hard

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - celecoxib - hard capsule - celecoxib 200 mg - antiinflammatory and antirheumatic products

Rivaroxaban Sandoz 2.5 mg, film-coated tablets Malta - İngilizce - Medicines Authority

rivaroxaban sandoz 2.5 mg, film-coated tablets

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - rivaroxaban - film-coated tablet - rivaroxaban 2.5 mg - antithrombotic agents

Deferasirox Sandoz deferasirox 360 mg film-coated tablet blister pack Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

deferasirox sandoz deferasirox 360 mg film-coated tablet blister pack

sandoz pty ltd - deferasirox, quantity: 360 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; crospovidone; povidone; magnesium stearate; colloidal anhydrous silica; poloxamer; hypromellose; titanium dioxide; macrogol 4000; purified talc; indigo carmine aluminium lake - the treatment of chronic iron overload due to blood transfusions (transfusional haemosiderosis) in adults and paediatric patients 6 years and older. deferasirox sandoz is also indicated for the treatment of chronic iron overload in paediatric patients aged 2 to 5 years who are unable to take desferrioxamine therapy or in whom desferrioxamine has proven ineffective. deferasirox sandoz is also indicated for the treatment of chronic iron overload in patients with non-transfusion-dependent thalassemia syndromes aged 10 years and older.

Deferasirox Sandoz deferasirox 180 mg film-coated tablet blister pack Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

deferasirox sandoz deferasirox 180 mg film-coated tablet blister pack

sandoz pty ltd - deferasirox, quantity: 180 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; crospovidone; povidone; magnesium stearate; colloidal anhydrous silica; poloxamer; hypromellose; titanium dioxide; macrogol 4000; purified talc; indigo carmine aluminium lake - the treatment of chronic iron overload due to blood transfusions (transfusional haemosiderosis) in adults and paediatric patients 6 years and older. deferasirox sandoz is also indicated for the treatment of chronic iron overload in paediatric patients aged 2 to 5 years who are unable to take desferrioxamine therapy or in whom desferrioxamine has proven ineffective. deferasirox sandoz is also indicated for the treatment of chronic iron overload in patients with non-transfusion-dependent thalassemia syndromes aged 10 years and older.

Deferasirox Sandoz deferasirox 90 mg film-coated tablet blister pack Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

deferasirox sandoz deferasirox 90 mg film-coated tablet blister pack

sandoz pty ltd - deferasirox, quantity: 90 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; crospovidone; povidone; magnesium stearate; colloidal anhydrous silica; poloxamer; hypromellose; titanium dioxide; macrogol 4000; purified talc; indigo carmine aluminium lake - the treatment of chronic iron overload due to blood transfusions (transfusional haemosiderosis) in adults and paediatric patients 6 years and older. deferasirox sandoz is also indicated for the treatment of chronic iron overload in paediatric patients aged 2 to 5 years who are unable to take desferrioxamine therapy or in whom desferrioxamine has proven ineffective. deferasirox sandoz is also indicated for the treatment of chronic iron overload in patients with non-transfusion-dependent thalassemia syndromes aged 10 years and older.

Calcipotriol/Betamethasone Sandoz Ointment 50mcg per g/ 500mcg per g Malta - İngilizce - Medicines Authority

calcipotriol/betamethasone sandoz ointment 50mcg per g/ 500mcg per g

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - calcipotriol monohydrate, betamethasone dipropionate - ointment - calcipotriol monohydrate 50 µg/g betamethasone dipropionate 0.5 mg/g - antipsoriatics

Abiraterone Sandoz 500 mg film-coated tablets Malta - İngilizce - Medicines Authority

abiraterone sandoz 500 mg film-coated tablets

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - film-coated tablet - abiraterone acetate 500 mg - endocrine therapy

FINGOLIMOD SANDOZ fingolimod (as hydrochloride) 0.25 mg capsule blister pack Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

fingolimod sandoz fingolimod (as hydrochloride) 0.25 mg capsule blister pack

sandoz pty ltd - fingolimod hydrochloride, quantity: 0.28 mg (equivalent: fingolimod, qty 0.25 mg) - capsule, hard - excipient ingredients: mannitol; hyprolose; hydroxypropylbetadex; magnesium stearate; shellac; iron oxide black; propylene glycol; gelatin; strong ammonia solution; titanium dioxide; iron oxide yellow - fingolimod sandoz is indicated for the treatment of adult and paediatric patients of 10 years of age and above with relapsing forms of multiple sclerosis to reduce the frequency of relapses and to delay the progression of disability.